These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2485607)
1. The influence of propranolol on the hypotensive action of ketanserin in normotensive rats. Malinowska B; Pietraszek M; Chabielska E; Buczko W Acta Physiol Pol; 1989; 40(4):356-62. PubMed ID: 2485607 [TBL] [Abstract][Full Text] [Related]
2. Peripheral and central cardiovascular effects of ketanserin in conscious normotensive rats. Davy M; Midol-Monnet M; Heimburger M; Beslot F; Cohen Y Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):193-206. PubMed ID: 3128194 [TBL] [Abstract][Full Text] [Related]
3. Central sympathoinhibitory action of ketanserin in rats. Yoshioka M; Matsumoto M; Togashi H; Minami M; Saito H J Pharmacol Exp Ther; 1987 Dec; 243(3):1174-8. PubMed ID: 3694531 [TBL] [Abstract][Full Text] [Related]
4. Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats. Mollace V; De Francesco EA; Fersini G; Nisticò G Funct Neurol; 1991; 6(2):101-6. PubMed ID: 1655588 [TBL] [Abstract][Full Text] [Related]
5. Differences in the chronic hypotensive mechanism of action of ketanserin in spontaneously hypertensive and Wistar-Kyoto rats. Balasubramaniam G; Lee HS; Mah SC J Hypertens; 1994 Jan; 12(1):7-14. PubMed ID: 8157947 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system. Savci V; Cavun S; Goktalay G; Ulus IH Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025 [TBL] [Abstract][Full Text] [Related]
7. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628 [TBL] [Abstract][Full Text] [Related]
8. Examinations on contribution of bradykinin in the action of dopamine in circulatory system of rats. I. Influence of bradykinin in the action of dopamine on arterial blood pressure of rats. Fiedorowicz R; Moniuszko-Jakoniuk J; Wiśniewski K Arch Immunol Ther Exp (Warsz); 1983; 31(5):739-48. PubMed ID: 6675575 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats. Polio J; Sieber CC; Lerner E; Groszmann RJ Hepatology; 1993 Jul; 18(1):128-36. PubMed ID: 8325604 [TBL] [Abstract][Full Text] [Related]
10. Lack of effect of propranolol on the steady-state plasma levels of ketanserin. Trenk D; Lühr A; Radkow N; Jähnchen E Arzneimittelforschung; 1985; 35(8):1286-8. PubMed ID: 2934070 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms. Yalcin M; Savci V Neuropeptides; 2007 Dec; 41(6):465-75. PubMed ID: 17897713 [TBL] [Abstract][Full Text] [Related]
12. C1 area of the rostral ventrolateral medulla as a site for the central hypotensive action of propranolol. Privitera PJ; Granata AR; Underwood MD; Gaffney TE; Reis DJ J Pharmacol Exp Ther; 1988 Aug; 246(2):529-33. PubMed ID: 3404445 [TBL] [Abstract][Full Text] [Related]
13. Is the antihypertensive effect of propranolol caused by an action within the central nervous system? Smits JF; van Essen H; Struyker-Boudier HA J Pharmacol Exp Ther; 1980 Oct; 215(1):221-5. PubMed ID: 7452486 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms underlying the cardiovascular effects of a labdenic diterpene isolated from Moldenhawera nutans in normotensive rats. Lahlou S; de Barros Correia CA; Vasconcelos Dos Santos M; David JM; David JP; Duarte GP; Magalhães PJ Vascul Pharmacol; 2007 Jan; 46(1):60-6. PubMed ID: 16875882 [TBL] [Abstract][Full Text] [Related]
15. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats. Orallo F Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696 [TBL] [Abstract][Full Text] [Related]
16. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B. Wiśniewska RJ Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629 [TBL] [Abstract][Full Text] [Related]
17. The beta 2 receptor plays a role in the hypotensive effect of L-dopa. Quevedo M; Prieto JC; Pérez-Olea J Acta Physiol Pharmacol Ther Latinoam; 1995; 45(1):19-25. PubMed ID: 8580515 [TBL] [Abstract][Full Text] [Related]
18. Studies on the hypotensive response to atropine in hypertensive rats. Abraham S; Cantor EH; Spector S J Pharmacol Exp Ther; 1981 Sep; 218(3):662-8. PubMed ID: 6115051 [TBL] [Abstract][Full Text] [Related]
19. Possible role of an endogenous opioid in the antihypertensive action of propranolol in spontaneously hypertensive rats. Farsang C; Ramirez-Gonzalez MD; Tchakarov L; Kunos G Acta Physiol Hung; 1983; 62(2):167-75. PubMed ID: 6670566 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats. Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]